Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm

MLA

Koichiro Fukuchi, et al. “Mutated ZRSR2 and CUL3 Accelerate Clonal Evolution and Confer Venetoclax Resistance via RAS Signaling Pathway in Blastic Plasmacytoid Dendritic Cell Neoplasm.” International Journal of Hematology, Apr. 2023. EBSCOhost, https://doi.org/10.1007/s12185-023-03597-9.

APA

Koichiro Fukuchi, Daisuke Koyama, Maki Takada, Hirotaka Mori, Kiyohito Hayashi, Naomi Asano, Yuki Sato, Masahiko Fukatsu, Motoki Takano, Hiroshi Takahashi, Kayo Shirado-Harada, Satoshi Kimura, Toshiyuki Yamamoto, & Takayuki Ikezoe. (2023). Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm. International Journal of Hematology. https://doi.org/10.1007/s12185-023-03597-9

Chicago

Koichiro Fukuchi, Daisuke Koyama, Maki Takada, Hirotaka Mori, Kiyohito Hayashi, Naomi Asano, Yuki Sato, et al. 2023. “Mutated ZRSR2 and CUL3 Accelerate Clonal Evolution and Confer Venetoclax Resistance via RAS Signaling Pathway in Blastic Plasmacytoid Dendritic Cell Neoplasm.” International Journal of Hematology, April. doi:10.1007/s12185-023-03597-9.